Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
Analyst Yuen Low applauded moves by the company to make amendments to plans for the giant Woodsmith polyhalite fertiliser project in North Yorkshire that should simplify construction and reduce the environmental impact of work
There is significant demand for the company's Fovio platform and processor
It is currently looking for opportunities to accelerate components of the shaft and tunnel spend.
The company, headquartered in Durham, is now reaping the rewards of two years hard work as it is delivering the orders it has generated in that time
The two sides want time to finalise the “technical and financial elements” of a contract that will lift supply “beyond” 100 megawatts from 50 megawatts currently.
The ImmunoBody technology was used to develop SCIB1 and SCIB2 – the company’s leading drug candidates.
Seppo Mäkinen, Dr Ajay Agrawal and Andrew King bring with them a wealth of industry and commercial experience
Dr David Huang will present at IDWeek 2017 on October 7 where he will give an overview of the REVIVE-1 phase-III clinical study
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.